Christine Gebski - Feb 17, 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
SVP, Filtration & Chromatography
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Feb 17, 2022
Transactions value $
-$40,862
Form type
4
Date filed
2/22/2022, 06:31 PM
Previous filing
Sep 2, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Award $0 +450 +1.35% $0.00 33.8K Feb 17, 2022 Direct F1
transaction RGEN Common Stock Tax liability -$40.9K -224 -0.66% $182.42 33.5K Feb 17, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on January 4, 2021. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F2 Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.

Remarks:

SVP, Filtration & Chromatography